BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Deals

Onyx, Ono Pharmaceutical deal

Onyx granted Ono exclusive, Japanese rights to develop and commercialize two proteasome inhibitors for cancer. Onyx will receive about $59 million up front and is eligible for...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >